Credit Suisse Leads Initial Purchasers in Senior Notes Financing for Acquisition of Syniverse
December 23, 2010
Cravath represented Credit Suisse Securities (USA) LLC, Barclays Capital Inc. and Goldman, Sachs & Co. in their roles as the initial purchasers of $475 million of senior notes of Buccaneer Merger Sub, Inc. (“Buccaneer”) in a Rule 144A offering that closed on December 22, 2010. Buccaneer is owned by a fund managed by The Carlyle Group and will serve as the acquisition vehicle for Carlyle’s leveraged buy-out of Syniverse Holdings, Inc. (“Syniverse”) in a transaction valued at $2.7 billion. Syniverse is a leading global provider of interoperability services used by wireless telephone carriers. The proceeds of the Buccaneer notes have been placed into escrow and will be available as a source of financing for the acquisition, pending satisfaction of customary closing conditions.
The Cravath team included partner Craig F. Arcella and associates Stephen M. Kessing, Todd D.C. Anderman and Aikaterini Kousoula. J. Paul Hoest also worked on the offering.
Related Practices & Industries
People
- Photo
-
-
J.D., 1998, Columbia Law SchoolHarlan Fiske Stone Scholar
-
B.A., 1995, Duke University
- New York
Education
Admitted In
- Photo
-
-
J.D., 2005, Duke Law SchoolOrder of the Coif, magna cum laude
-
M.B.A., 2001, University of Southern California
-
B.S., 1995, Miami University of Ohio
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
February 20, 2026
First Solar’s $1.5 Billion Revolving Credit Facility
Cravath represented First Solar, Inc. in connection with its $1.5 billion revolving credit facility. First Solar is America’s leading photovoltaic solar technology and manufacturing company, and the only US‑headquartered company among the world’s largest solar manufacturers. The transaction closed on February 13, 2026.
Deals & Cases
January 08, 2026
Genmab’s $3.5 Billion of Credit Facilities and Offering of $1.5 Billion Senior Secured Notes and $1 Billion Senior Unsecured Notes in Connection with its Acquisition of Merus
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $3.5 billion of credit facilities made available to Genmab, a leading international biotechnology company, and one of its wholly‑owned subsidiaries, Genmab Finance LLC, as part of the financing transactions undertaken in connection with its acquisition of Merus N.V., a leading oncology company developing innovative antibody therapeutics. The credit facilities consisted of a $2 billion term loan “B” facility, a $1 billion term loan “A” facility and a $500 million revolving credit facility. The transaction closed on December 12, 2025.
Deals & Cases
December 24, 2025
Ameren’s $3.2 Billion of Revolving Credit Facilities
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with $3.2 billion of revolving credit facilities made available to Ameren Corporation and Union Electric Company (the “Missouri Borrowers”) and Ameren Corporation and Ameren Illinois Company (the “Illinois Borrowers”). Ameren Corporation is an American power company that engages in the rate‑regulated electric generation, transmission and distribution activities; and rate‑regulated natural gas distribution and transmission businesses. The facilities consisted of a $1.9 billion revolving credit facility (Missouri Borrowers) and $1.3 billion revolving credit facility (Illinois Borrowers). The transaction closed on December 10, 2025.
Deals & Cases
November 24, 2025
Thomson Reuters Corporation’s $2 Billion Revolving Credit Facility
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with a $2 billion revolving credit facility made available to Thomson Reuters Corporation, a leading AI and technology company empowering professionals with trusted content and workflow automation. The transaction closed on November 10, 2025.
